Red X iconGreen tick iconYellow tick icon

Contact Details

+64 3 479 4262
Professor and Associate Dean (Research)
MPharm PhD
Research summary
Drug formulation and delivery, drug delivery to the lung


  • PHCY 211 Fundamental Pharmaceutical Sciences
  • PHCY 220 Integrated modules A
  • PHCY 310 Integrated modules B
  • PHCY 430 Elective Projects B
  • PHCY 480 Honours Research Project
  • PHCY 485 Applied Pharmacotherapy and Patient Care for Honours
  • PSCI 204 Formulation Principles 2
  • PSCI 305 Drug Delivery
  • Inter Professional education


  • Programme Co-ordinator for BPharm(Hons) programme
  • PHCY 480 Honours Research Project (Course Co-ordinator)
  • PHCY 485 Applied Pharmacotherapy and Patient Care for Honours (Course Co-ordinator)
  • PSCI 305 Drug Delivery
  • Editorial Board: International Journal of Pharmaceutics (Q1, 16th/171 journals in pharmaceutical science, Citescore: 9.6 (Scopus 2021) (2018 to present)
  • Guest editor, International Journal of Pharmaceutics special issue on ‘The respiratory delivery of high dose powders’ (2018) and 'in honor of Ian Tucker' (2021 to 2022)
  • Editorial Board Member, Pharmaceutics (2022 to present)
  • Associate Editor, Frontiers Drug Delivery Pulmonary Drug Delivery (2021 to present)
  • Scientific Advisory Committee member, Drug Delivery to the Lung Conference (2015 to Present)
  • The Aerosol Society (2013 to present)
  • Australasian Pharmaceutical Science Association (APSA) (2006 to present)
  • Otago Medical School Research Society: President (2023 to 2024), Vice-President (2021 to 2022), Treasurer (2019 to present), Executive Committee Member (2018)
  • New Zealand Chapter of the Controlled Release Society (2013 to present): President Elect (2021 to present), Treasurer (2019 to 2021), Executive Committee Member (2017 to 2019)
  • Otago Global Health Institute: Profiled Network Member (2016 to present)
  • Associate Invesigator, Maurice Wilkins Centre (2022 to present)


The research interests of Professor Das revolve around drug delivery, in particular, respiratory drug delivery of powder formulations for treating chronic lung conditions such as COPD, asthma, tuberculosis, lung cancer and lung infections.

His aim is to achieve a fundamental knowledge base on solid state characterisation processes to understand various pharmaceutical processes such as milling, mixing, spray drying, amorphisation, micronisation, crystallisation, relaxation, dissolution, coating and storage. These knowledge and innovating approaches can be used to develop various conventional and controlled release solid dosage forms such as powders for respiratory delivery as well as tablets and capsules for oral delivery.

Professor Das has extensive research networks with collaborators in New Zealand, Australia, Europe, Asia, the United Kingdom and the USA.
For more visit Das laboratory

PhD projects available

Please contact me if you are interested in conducting PhD research in the following areas:

  • Interactions and influence of lung surfactant on dissolution in the lung
  • Solid surface characteristics that influence powder delivery to the lung


Professor Shyamal Das lectures in Pharmaceutical Science at the School of Pharmacy, University of Otago. He is an internationally recognised formulation expert with over 15 years of experience in dry powder inhaler technology.

Professor Das supervises a large productive research group which focuses on drug delivery to the lung to improve therapy for chronic lung conditions such as asthma, chronic obstructive pulmonary disease, cystic fibrosis and tuberculosis. He is currently contributing to the development of inhalers to treat coronaviruses in collaboration with academia and industries.

Professor Das completed his PhD and research fellowships at Monash Institute of Pharmaceutical Sciences. He was a visiting researcher at the University College London (UK), Imperial College London (UK) and the University of Texas at Austin (USA).

Professor Das is also an award-winning passionate lecturer. He has won multiple awards for best teaching and supervision at the University of Otago.

Additional details

Previous positions

  • Research Fellow, Monash Institute of Pharmaceutical Sciences, Monash University, Australia (2008–2013)
  • Teaching Assistant, Department of Pharmaceutics and Department of Pharmacy Practice, Monash University, Australia (2005–2008)
  • Assistant Professor, Department of Pharmacy, Jahangirnagar University, Bangladesh (2003–2004)
  • Lecturer, Department of Pharmacy, Jahangirnagar University, Bangladesh (2000–2003)

Teaching and research awards

  • United Kingdom Council for Graduate Education (UKCGE) Recognised Research Supervisor 2022
  • Winner of the School of Pharmacy (SOP) Best Research Paper Award 2021, 2020 and 2019
  • Winner of the Otago University Students’ Association’s 2017 Teaching Excellence Award: Premier Lecturer Award 2017 Division of Health Sciences
  • Winner of the Otago University Students’ Association’s Supervisor of the Year Award 2017 Division of Health Sciences
  • Winner of the School of Pharmacy’s Excellence in Teaching Award 2016
  • Winner of the Otago University Students’ Association’s 2016 Teaching Excellence Award (Top Five Teacher)
  • Winner of the Otago School of Pharmacy’s Emerging Researcher Award 2016
  • Finalist (top five) for the Australasian Pharmaceutical Scientists Association’s 2016 Early Career Investigator Award
  • Health Research Council of New Zealand’s Emerging Researcher First Grant 2015

School of Pharmacy administrative roles

  • Associate Dean Research (August 2021- Present)
  • School’s representative to Division of Health Science Research Committee
  • Chair, BPharm(Hons) Committee (since 2014)
  • Co-Chair, School of Pharmacy Research Committee (since 2020) and Member since February 2017)
  • Member, Research and Postgraduate Committee (since March 2019)
  • Member, School of Pharmacy Undergraduate Programmes Committee
  • Member, School of Pharmacy BPharm/BPharm(Hons) Curriculum Committee (since November 2017)
  • Self-Review Coordinator of BPharm(Hons) Programme (2018)
  • Member, School of Pharmacy Admission Working Party (June 2016 to June 2018)


Hare, C., Hadinoto, K., Das, S., & Smith, R. (2024). Dry powder coating in manufacturing processes. Frontiers in Chemical Engineering, 6, 1420110. doi: 10.3389/fceng.2024.1420110 Journal - Research Other

Fan, C., Eedara, B. B., Sinha, S., Udden, M. K. M., Doyle, C., Banu, S., & Das, S. C. (2024). Triple combination dry powder formulation of pretomanid, moxifloxacin, and pyrazinamide for treatment of multidrug-resistant tuberculosis. International Journal of Pharmaceutics, 654, 123874. doi: 10.1016/j.ijpharm.2024.123984 Journal - Research Article

Khadka, P., Dummer, J., Hill, P. C., & Das, S. C. (2024). The quest to deliver high-dose rifampicin: Can the inhaled approach help? [Review]. Expert Opinion on Drug Delivery, 21(1), 31-44. doi: 10.1080/17425247.2024.2301931 Journal - Research Other

Saha, T., Lyons, N., Yung, D. B. Y., Quiñones‑Mateu, M. E., Pletzer, D., & Das, S. C. (2024). Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections. European Journal of Pharmaceutics & Biopharmaceutics, 195, 114170. doi: 10.1016/j.ejpb.2023.12.010 Journal - Research Article

Komal, K., Chen, S., Glass, M., & Das, S. C. (2023). Inhalable cannabidiol dry powder for treating chronic obstructive pulmonary disease. Proceedings of the New Zealand Controlled Release Society (NZCRS) Symposium. Retrieved from Conference Contribution - Published proceedings: Abstract

Back to top